Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
2024-2033 Forecast: What is the Projected Growth Rate for the RNA Targeting Small Molecules Therapeutics Market?
The market size for RNA targeting small molecules therapeutics has experienced remarkable growth recently. It’s anticipated to expand from a value of $1.06 billion in 2023 to $1.45 billion in 2024, with a compound annual growth rate (CAGR) of 37.0%. The historic surge can be traced back to factors such as developments in drug discovery, an increase in RNA-related diseases, government and private funding, interest from the pharmaceutical industry, and the success stories of RNA therapeutics.
The market for RNA targeting small molecules therapeutics is projected to experience a surge in size over the coming years. The market is forecasted to increase to $5.09 billion by 2028, with a compound annual growth rate (CAGR) of 36.9%. The projected growth during this period can be linked to the rise of precision medicine and personalized therapies, the increase in RNA biomarker identification, an expanded RNA target spectrum, and increased funding and investments, particularly for rare disease applications. Other significant trends projected for this forecast period include advances in screening technologies, the domination of antisense oligonucleotides, the emergence of small molecule RNA binders, the use of RNA therapeutics in neurological disorders, and genetic modification with CRISPR-Cas9.
Claim Your Free Sample of the Global RNA Targeting Small Molecules Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12253&type=smp
What Are the Main Drivers Behind the Growth of the rna targeting small molecules therapeutics Market?
The surge in cancer diagnoses is predicted to stimulate the expansion of the RNA-targeting small molecule therapeutics market in the future. This family of diseases, known as cancer, can erupt in almost any organ or tissue when abnormal cells multiply beyond their usual limits and encroach on adjacent body parts or metastasize to other organs. These anomalies are treated using RNA-targeting small molecules, which are designed and tested to specifically target cancer-associated RNA molecules. For example, the American Cancer Society, a health organization based in the US, reported in January 2022 that the US is expected to witness 609,360 cancer-related fatalities and approximately 1.9 million new cancer cases in 2022, which equates to roughly 1,670 deaths every day. Hence, the surge in cancer diagnoses is propelling the expansion of the RNA-targeting small molecule therapeutics market.
What Are the Primary Segments of the RNA Targeting Small Molecules Therapeutics Market?
1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings
2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications
3) By Application: Drug Discovery, Oncology Research, Disease Identification
4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users
Which Trends Are Revolutionizing the RNA Targeting Small Molecules Therapeutics Market?
The rise of strategic collaborations is a significant trend in the RNA-targeting small molecule therapeutics market. Major market players are establishing partnerships to foster novel relationships and create innovative products. For instance, Otsuka Pharmaceutical Co. Ltd., a pharmaceutical manufacturer based in Japan, joined forces with xFOREST Therapeutics Co. Ltd., a Japanese drug discovery platform developer, in June 2022. Through this alliance, xFOREST will provide its Forest technology to Otsuka to propel forward-looking research in systemic small-molecule drug discovery targeting RNA structures. Moreover, in March 2021, a strategic partnership was formed between Evotec SE, a German drug discovery and development firm, and Takeda Pharmaceutical Company Limited, a pharmaceutical company in Japan. The purpose of this collaboration is to discover and develop RNA-targeting small molecules.
Order Now for Fast Delivery of Your RNA Targeting Small Molecules Therapeutics Market Report!
Which Geographical Regions Are Pioneering Growth in the RNA Targeting Small Molecules Therapeutics Market?
North America was the largest region in the RNA targeting small molecules therapeutics market in 2023. The regions covered in the rna targeting small molecules therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The RNA Targeting Small Molecules Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the rna targeting small molecules therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The RNA Targeting Small Molecules Therapeutics Market Include
1. RNA Targeting Small Molecules Therapeutics Market Executive Summary
2. RNA Targeting Small Molecules Therapeutics Market Segments
3. RNA Targeting Small Molecules Therapeutics Market Size And Template Market Growth Rate
4. Key RNA Targeting Small Molecules Therapeutics Market Trends
5. Major RNA Targeting Small Molecules Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The RNA Targeting Small Molecules Therapeutics Market
26. Top RNA Targeting Small Molecules Therapeutics Companies
27. RNA Targeting Small Molecules Therapeutics Market Opportunities And Strategies
28. RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Antisense & RNAi Therapeutics Global Market Report 2024
Cystic Fibrosis (CF) Therapeutics Global Market Report 2024
Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
